Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Proximal spinal muscular atrophy (SMA) is a common neuromuscular disorder causing infant death in half of all patients. Homozygous absence of the survival motor neuron gene (SMN1) is the primary cause of SMA, while SMA severity is mainly determined by the number of SMN2 copies. One SMN2 copy produces only about 10% of full-length protein identical to SMN1, whereas the majority of SMN2 transcripts is aberrantly spliced due to a silent mutation within an exonic splicing enhancer in exon 7. However, correct splicing can be restored by over-expression of the SR-like splicing factor Htra2-beta 1. We show that in fibroblast cultures derived from SMA patients treated with therapeutic doses (0.5-500 microM) of valproic acid (VPA), the level of full-length SMN2 mRNA/protein increased 2- to 4-fold. Importantly, this up-regulation of SMN could be most likely attributed to increased levels of Htra2-beta 1 which facilitates the correct splicing of SMN2 RNA as well as to an SMN gene transcription activation. Especially at low VPA concentrations, the restored SMN level depended on the number of SMN2 copies. Moreover, VPA was able to increase SMN protein levels through transcription activation in organotypic hippocampal brain slices from rats. Finally, VPA also increased the expression of further SR proteins, which may have important implications for other disorders affected by alternative splicing. Since VPA is a drug highly successfully used in long-term epilepsy therapy, our findings open the exciting perspective for a first causal therapy of an inherited disease by elevating the SMN2 transcription level and restoring its correct splicing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
A simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P.-A., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,089
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
What's Up and Down with Histone Deacetylation and Transcription?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 821
Cartegni, L., & Krainer, A. R. (2002) · Nature Genetics · doi:10.1038/ng854 · Cited by 730
Wirth, B. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3<228::aid-humu3>3.0.co;2-9 · Cited by 667
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany)
Munsat, T. L., & Davies, K. E. (1992) · Neuromuscular Disorders · doi:10.1016/s0960-8966(06)80015-5 · Cited by 666
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Liu, Q., Fischer, U., Wang, F., & Dreyfuss, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80367-0 · Cited by 657
The dynamics of a pre-mRNA splicing factor in living cells
Misteli, T., Cáceres, J. F., & Spector, D. L. (1997) · Nature · doi:10.1038/387523a0 · Cited by 619
A Novel Function for SMN, the Spinal Muscular Atrophy Disease Gene Product, in Pre-mRNA Splicing
Pellizzoni, L., Kataoka, N., Charroux, B., & Dreyfuss, G. (1998) · Cell · doi:10.1016/s0092-8674(00)81632-3 · Cited by 558
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
Kashima, T., & Manley, J. L. (2003) · Nature Genetics · doi:10.1038/ng1207 · Cited by 546
SMN oligomerization defect correlates with spinal muscular atrophy severity
Lorson, C. L., Strasswimmer, J., Yao, J.-M., Baleja, J. D., Hahnen, E., Wirth, B., Le, T., Burghes, A. H. M., & Androphy, E. J. (1998) · Nature Genetics · doi:10.1038/ng0598-63 · Cited by 500
Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.
Pearn, J. (1978) · Journal of Medical Genetics · doi:10.1136/jmg.15.6.409 · Cited by 472
Treatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
Mechanisms of action of valproate: a commentatory
Johannessen, C. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00013-9 · Cited by 399
Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J., & Wirth, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160181697 · Cited by 314
Correction of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
Rossoll, W. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.1.93 · Cited by 287
When Is a Deletion Not a Deletion? When It Is Converted
Burghes, A. H. M. (1997) · The American Journal of Human Genetics · doi:10.1086/513913 · Cited by 277
The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation
Jumaa, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.5077 · Cited by 272
Anti‐tumor mechanisms of valproate: A novel role for an old drug
Blaheta, R. A., & Cinatl, J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10017 · Cited by 269
International SMA consortium meeting
Munsat, T. L. (1992) · Medical Entomology and Zoology · Cited by 243
Andreassi, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2841 · Cited by 229
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes
Wuyts, W. A., & Hul, W. V. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3<209::aid-humu1>3.0.co;2-k · Cited by 220
Hofmann, Y. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.2037 · Cited by 193
Young, P. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.577 · Cited by 143
Ml, Z., Lorson, C., Androphy, E. J., & Zhou, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301550 · Cited by 140
Helmken, C., Hofmann, Y., Schoenen, F. J., Oprea, G. E., Raschke, H., Rudnik-Sch�neborn, S., Zerres, K., & Wirth, B. (2003) · Human Genetics · doi:10.1007/s00439-003-1025-2 · Cited by 125
Pregnancy and the Risk of Teratogenicity
Lindhout, D., & Omtzigt, J. G. C. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb06226.x · Cited by 119
Thalidomide, a current teratogen in South America
Castilla, E. E., Ashton‐Prolla, P., Barreda‐Mejia, E., Brunoni, D., Cavalcanti, D. P., Correa‐Neto, J., Delgadillo, J. L., Dutra, M. G., Felix, T., Giraldo, A., et al. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199612)54:6<273::aid-tera1>3.0.co;2-# · Cited by 105
Nayler, O., Cap, C., & Stamm, S. (1998) · Genomics · doi:10.1006/geno.1998.5471 · Cited by 100
Echaniz‐Laguna, A., Miniou, P., Bartholdi, D., & Melki, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302372 · Cited by 87
Best practice guidelines for molecular analysis in spinal muscular atrophy
Scheffer, H., Cobben, J. M., Matthijs, G., & Wirth, B. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200667 · Cited by 77
Valproic acid-induced changes in gene expression during neurulation in a mouse model
Wlodarczyk, B. J., Craig, J. C., Bennett, G. D., Calvin, J. A., & Finnell, R. H. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199612)54:6<284::aid-tera3>3.0.co;2-z · Cited by 61
Wieser, H. G. (1991) · Epilepsy Research · doi:10.1016/0920-1211(91)90028-e · Cited by 43
Sp Family of Transcription Factors Is Involved in Valproic Acid-induced Expression of Gαi2
Arinze, I., & Kawai, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209430200 · Cited by 41
Entorhinal cortex lesion studied with the novel dye Fluoro-Jade
Savaskan, N. E., Eyüpoglu, I. Y., Bräuer, A. U., Plaschke, M., Ninnemann, O., Nitsch, R., & Skutella, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02148-x · Cited by 27
Labiner, D. M. (2002) · PubMed · Cited by 14
Antitumor Mechanisms of Valproate: A Novel Role for an Old Drug
Blaheta, R. A., & Cinatl, J. J. (2002) · ChemInform · doi:10.1002/chin.200245278 · Cited by 14
Cited by
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Lunn, M. R., & Wang, C. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60921-6 · Cited by 995
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Metadata
- Authors
- Brichta, L.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Brichta, L.
- ORCID
- Brichta, L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-05
- Volume
- 12
- Issue
- 19
- Pages
- 2481-2489
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2151318390
- Cited by
- 382
- References
- 41
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 12 · 2018: 8 · 2017: 11 · 2016: 14 · 2015: 15 · 2014: 15 · 2013: 31 · 2012: 18
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- valproic acid, spinal muscular atrophy, SMN2, SMN1, SR proteins, alternative splicing, exonic splicing enhancers, drug repurposing, inherited neuromuscular disease
- MeSH terms
- Animals, Antibodies, Monoclonal, Cells, Cultured, Dose-Response Relationship, Drug, Exons, Fibroblasts, Gene Expression Regulation, Hippocampus, Humans, Muscular Atrophy, Spinal, Nerve Tissue Proteins, Organ Culture Techniques, RNA Splicing, RNA, Messenger, Time Factors, Transcription, Genetic, Valproic Acid, Blotting, Western, Genetic Therapy, Rats, Wistar, Gene Deletion, GABA Agents, Reverse Transcriptase Polymerase Chain Reaction, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.